Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


24.06.2024

8 Antiviral Res
2 Biochemistry (Mosc)
1 BMC Pediatr
17 BMJ
1 Drug Saf
1 J Clin Microbiol
7 J Infect
1 J Virol Methods
2 JAMA
6 Lancet
1 N Engl J Med
1 PLoS Comput Biol
18 PLoS One
2 Proc Natl Acad Sci U S A
1 Vaccine
1 Virology
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antiviral Res

  1. AMERATUNGA R, Jordan A, Lehnert K, Leung E, et al
    SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
    Antiviral Res. 2024 Apr 25:105894. doi: 10.1016/j.antiviral.2024.105894.
    PubMed         Abstract available

  2. SUN Y, Wagatsuma K, Saito R, Sato I, et al
    Duration of fever in children infected with influenza A(H1N1)pdm09, A(H3N2) or B virus and treated with baloxavir marboxil, oseltamivir, laninamivir, or zanamivir in Japan during the 2012-2013 and 2019-2020 influenza seasons.
    Antiviral Res. 2024 Jun 17:105938. doi: 10.1016/j.antiviral.2024.105938.
    PubMed         Abstract available

  3. LE UNP, Chang YJ, Lu CH, Chen Y, et al
    Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants.
    Antiviral Res. 2024;227:105920.
    PubMed         Abstract available

  4. LIANG Y, Xiao W, Peng Y, Zhang S, et al
    Development of Nanoparticle Vaccines Utilizing Designed Fc-Binding Homo-oligomers and RBD-Fc of SARS-CoV-2.
    Antiviral Res. 2024 May 21:105917. doi: 10.1016/j.antiviral.2024.105917.
    PubMed         Abstract available

  5. BONNEUX B, Shareef A, Tcherniuk S, Anson B, et al
    JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase.
    Antiviral Res. 2024;227:105907.
    PubMed         Abstract available

  6. HUANG J, Wang W, Li H, Bai Y, et al
    Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2.
    Antiviral Res. 2024;227:105905.
    PubMed         Abstract available

  7. PANDEY K, Acharya A, Pal D, Jain P, et al
    SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.
    Antiviral Res. 2024;227:105904.
    PubMed         Abstract available

  8. SALGADO-BENVINDO C, Tas A, Zevenhoven-Dobbe JC, van der Meer Y, et al
    Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: a versatile and practical infection model for antiviral research and beyond.
    Antiviral Res. 2024 May 7:105903. doi: 10.1016/j.antiviral.2024.105903.
    PubMed         Abstract available


    Biochemistry (Mosc)

  9. AFRIDONOVA ZE, Toptygina AP, Mikhaylov IS
    Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins.
    Biochemistry (Mosc). 2024;89:872-882.
    PubMed         Abstract available

  10. ASTAKHOVA EA, Morozov AA, Vavilova JD, Filatov AV, et al
    Antigenic Cartography of SARS-CoV-2.
    Biochemistry (Mosc). 2024;89:862-871.
    PubMed         Abstract available


    BMC Pediatr

  11. UPPALA R, Seenoikhao N, Sitthikarnkha P, Niamsanit S, et al
    Clinical characteristics and prognostic marker for hospitalization in children with influenza infection in an emergency setting.
    BMC Pediatr. 2024;24:399.
    PubMed         Abstract available


    BMJ

  12. MORGAN J
    "I wasn't alone after all"-how modelling vulnerability can support staff wellbeing.
    BMJ. 2024;385:q1313.
    PubMed        

  13. ALKHALDI M
    Call to boost the profile of the Middle East and north Africa region in global health.
    BMJ. 2024;385:q1272.
    PubMed        

  14. LIMB M
    Election watch: How credible are the main parties' pledges on the NHS?
    BMJ. 2024;385:q1320.
    PubMed        

  15. OXTOBY K
    Why I . . . go adventure sailing.
    BMJ. 2024;385:q1292.
    PubMed        

  16. IRWIN EM
    Knock, knock. Who's there? It's the senior house officers trying to come back . .
    BMJ. 2024;385:q1343.
    PubMed        

  17. POLKINGHORN A
    Thank you for waiting.
    BMJ. 2024;385:q1295.
    PubMed        

  18. FEINMANN J
    Analysis reveals global post-covid surge in infectious diseases.
    BMJ. 2024;385:q1348.
    PubMed        

  19. LAUNER J
    John Launer: Faces or candlesticks? Why we need continuity in teams.
    BMJ. 2024;385:q1323.
    PubMed        

  20. O'DOWD A
    World is woefully unprepared for another pandemic, experts warn.
    BMJ. 2024;385:q1355.
    PubMed        

  21. OLIVER D
    David Oliver: Will the actions pledged in Labour's election manifesto save health and social care?
    BMJ. 2024;385:q1326.
    PubMed        

  22. BUSE K, McKee M
    UK political parties pledge to strengthen security-yet ignore health security.
    BMJ. 2024;385:q1359.
    PubMed        

  23. ENRIA L, Dwyer H, Marchant M, Beckmann N, et al
    Political dimensions of misinformation, trust, and vaccine confidence in a digital age.
    BMJ. 2024;385:e079940.
    PubMed        

  24. VISWANATH K, Lee EJ, Dryer E
    Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
    BMJ. 2024;385:e076478.
    PubMed        

  25. FEINMANN J
    GP who confronted Rishi Sunak received "hundreds" of supportive messages from doctors.
    BMJ. 2024;385:q1375.
    PubMed        

  26. LIMB M
    Avoidable mortality in England and Wales remains higher than before pandemic, data show.
    BMJ. 2024;385:q1370.
    PubMed        

  27. NOLAN T
    Avian flu virus in raw milk ... and other research.
    BMJ. 2024;385:q1331.
    PubMed        

  28. IACOBUCCI G
    Junior doctors offer prime minister "final chance" to avoid pre-election strike.
    BMJ. 2024;385:q1367.
    PubMed        


    Drug Saf

  29. GORDILLO-MARANON M, Candore G, Hedenmalm K, Browne K, et al
    Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination.
    Drug Saf. 2024;47:607-615.
    PubMed         Abstract available


    J Clin Microbiol

  30. YU S-H, Kim K-J, Lee C-C, Puebla YP, et al
    Performance evaluation of the Panbio COVID-19/Flu A&B Panel for detection of SARS-CoV-2, influenza A, and influenza B antigens using mid-turbinate nasal swabs.
    J Clin Microbiol. 2024 Jun 18:e0020724. doi: 10.1128/jcm.00207.
    PubMed         Abstract available


    J Infect

  31. HALVORSEN B, Viermyr HK, Ueland T, Sagen EL, et al
    IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.
    J Infect. 2024 May 6:106176. doi: 10.1016/j.jinf.2024.106176.
    PubMed        

  32. KIRSEBOM FCM, Stowe J, Lopez Bernal J, Allen A, et al
    Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
    J Infect. 2024 May 6:106177. doi: 10.1016/j.jinf.2024.106177.
    PubMed         Abstract available

  33. AMANO M, Ichikawa Y, Matsumoto S, Higashi-Kuwata N, et al
    Neutralization activity of HCWs' sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination.
    J Infect. 2024;89:106179.
    PubMed        

  34. YANG X, Li X, Qiu S, Liu C, et al
    Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: a systematic review and meta-analysis of aggregated participant data.
    J Infect. 2024 May 14:106183. doi: 10.1016/j.jinf.2024.106183.
    PubMed         Abstract available

  35. MOKRANI D, Le Hingrat Q, Thy M, Choquet C, et al
    Clinical characteristics and outcomes of respiratory syncytial virus-associated ARF in immunocompetent patients: A seven-year experience at a tertiary hospital in France.
    J Infect. 2024;89:106180.
    PubMed         Abstract available

  36. HAN B, Li XM, Li R, Ning W, et al
    Epidemiological Surveillance of Acute Respiratory Infections Based on Targeted Metagenomic Next Generation Sequencing During the Flu Season after COVID-19 Pandemic in Beijing.
    J Infect. 2024 May 22:106188. doi: 10.1016/j.jinf.2024.106188.
    PubMed        

  37. ZHAI K, Dong J, Zeng J, Cheng P, et al
    Global Antigenic Landscape and Vaccine Recommendation Strategy for Low Pathogenic Avian Influenza A(H9N2) Viruses.
    J Infect. 2024 Jun 18:106199. doi: 10.1016/j.jinf.2024.106199.
    PubMed         Abstract available


    J Virol Methods

  38. MORECCHIATO F, Coppi M, Niccolai C, Antonelli A, et al
    Evaluation of different molecular systems for detection and quantification of SARS-CoV-2 RNA from wastewater samples.
    J Virol Methods. 2024;328:114956.
    PubMed         Abstract available


    JAMA

  39. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    PubMed        

  40. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed        


    Lancet

  41. ZAROCOSTAS J
    Mental health in emergencies requires "a major rethink".
    Lancet. 2024;403:2582.
    PubMed        

  42. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    PubMed        

  43. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed        

  44. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    PubMed        

  45. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    PubMed        

  46. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    PubMed        


    N Engl J Med


  47. Are We Prepared for Bird Flu?: ITT Episode 32.
    N Engl J Med. 2024;390:e59.
    PubMed        


    PLoS Comput Biol

  48. ROJAS CHAVEZ RA, Fili M, Han C, Rahman SA, et al
    Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics.
    PLoS Comput Biol. 2024;20:e1012215.
    PubMed         Abstract available


    PLoS One

  49. LIMA HS, Tupinambas U, Guimaraes FG
    Estimating time-varying epidemiological parameters and underreporting of Covid-19 cases in Brazil using a mathematical model with fuzzy transitions between epidemic periods.
    PLoS One. 2024;19:e0305522.
    PubMed         Abstract available

  50. KOLIVAND P, Saberian P, Arabloo J, Behzadifar M, et al
    Impact of COVID-19 pandemic on road traffic injuries in Iran: An interrupted time-series analysis.
    PLoS One. 2024;19:e0305081.
    PubMed         Abstract available

  51. POTTECHER J, Raffi F, Jandrot-Perrus M, Binay S, et al
    Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.
    PLoS One. 2024;19:e0302897.
    PubMed         Abstract available

  52. GORGELS KMF, Mujakovic S, Stallenberg E, Hackert VH, et al
    Implementation and effectiveness of non-pharmaceutical interventions, including mask mandates and ventilation, on SARS-CoV-2 transmission (alpha variant) in primary schools in the Netherlands.
    PLoS One. 2024;19:e0305195.
    PubMed         Abstract available

  53. WANG S, Ren J, Guo X
    A high-accuracy lightweight network model for X-ray image diagnosis: A case study of COVID detection.
    PLoS One. 2024;19:e0303049.
    PubMed         Abstract available

  54. LENNOX C, Duncan-Zaleski M, Nasim S, Shirley O, et al
    The impact of the COVID-19 pandemic for children in custody: An analysis of inspection reports.
    PLoS One. 2024;19:e0304862.
    PubMed         Abstract available

  55. REED DS, McElroy AK, Barbeau DJ, McMillen CM, et al
    No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.
    PLoS One. 2024;19:e0290909.
    PubMed         Abstract available

  56. ZAIDAN M, Puebla Neira D, Polychronopoulou E, Yong-Fang K, et al
    Healthcare utilization 9 months pre- and post- COVID-19 hospitalization among patients discharged alive.
    PLoS One. 2024;19:e0303509.
    PubMed         Abstract available

  57. CHERVO TC, Elkin EP, Nugent JR, Valice E, et al
    Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
    PLoS One. 2024;19:e0303303.
    PubMed         Abstract available

  58. DONAGHY R, Shinskey J, Tsakiris M
    Maternal interoceptive focus is associated with greater reported engagement in mother-infant stroking and rocking.
    PLoS One. 2024;19:e0302791.
    PubMed         Abstract available

  59. SETO E
    At freedom's edge: Belief in free will during the COVID-19 pandemic.
    PLoS One. 2024;19:e0303291.
    PubMed         Abstract available

  60. SANDBERG L, Bostrom AM, Hagstromer M, Lindgren C, et al
    Feasibility of the "Preventing functional decline in acutely hospitalized older patients (PREV_FUNC)" study-A three-armed randomized controlled pilot trial.
    PLoS One. 2024;19:e0304570.
    PubMed         Abstract available

  61. ZEBALLOS D, Magno L, Aranha Rossi T, Soares F, et al
    Performance of two rapid antigen tests against SARS-CoV-2 in neighborhoods of socioeconomic vulnerability from a middle-income country.
    PLoS One. 2024;19:e0298579.
    PubMed         Abstract available

  62. SHENEAMER AM, Halawi MH, Al-Qahtani MH
    A hybrid human recognition framework using machine learning and deep neural networks.
    PLoS One. 2024;19:e0300614.
    PubMed         Abstract available

  63. SCHOULTZ M, Mcgrogan C, Carolan C, Macaden L, et al
    Exploring barriers to care home research recruitment during the COVID-19 pandemic: The influence of social media recruitment posts and public sentiment.
    PLoS One. 2024;19:e0303609.
    PubMed         Abstract available

  64. GROVER EN, Buchwald AG, Ghosh D, Carlton EJ, et al
    Does behavior mediate the effect of weather on SARS-CoV-2 transmission? evidence from cell-phone data.
    PLoS One. 2024;19:e0305323.
    PubMed         Abstract available

  65. BASA M, De Vries J, McDonagh D, Comiskey C, et al
    The impact of COVID-19 on non-communicable disease patients in sub-Saharan African countries: A systematic review.
    PLoS One. 2024;19:e0293376.
    PubMed         Abstract available

  66. CHAMPREDON D, Papst I, Yusuf W
    ern: An [Formula: see text] package to estimate the effective reproduction number using clinical and wastewater surveillance data.
    PLoS One. 2024;19:e0305550.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  67. KIM H, Park HH, Kim HN, Seo D, et al
    The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases.
    Proc Natl Acad Sci U S A. 2024;121:e2319322121.
    PubMed         Abstract available

  68. TORTORICE D, Rappuoli R, Bloom DE
    The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2321978121.
    PubMed         Abstract available


    Vaccine

  69. CHENG TM, Chen YS, Wei KC, Chang YC, et al
    Assessment of the herpes zoster risk among renal transplant recipients administered the influenza vaccine.
    Vaccine. 2024 Jun 18:S0264-410X(24)00716-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology

  70. NAVEED A, Yu J, Lawson S, Gao R, et al
    Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
    Virology. 2024;597:110138.
    PubMed         Abstract available


    Virus Res

  71. RIVETTI AV JR, Reischak D, de Oliveira CHS, Otaka JNP, et al
    Phylodynamics of avian influenza A(H5N1) viruses from outbreaks in Brazil.
    Virus Res. 2024;347:199415.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.